All In MedTech

FDA Clearance Tracker · P140026-S027

ENROUTE Transcarotid Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 20, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P140026-S027
Device name
ENROUTE Transcarotid Stent System
Applicant location
Marborough, MA
Received
Jun 20, 2023
Decided
Jul 20, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P140026

Device type

Device class
Class III

Every decision under product code NIM

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the ROADSTER 3 post-approval study

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.